Trial testimony focuses on Lindsay Clancy's medications, fears of addiction

The murder trial of Lindsay Clancy continues with testimony regarding her mental health treatment and medication history prior to the 2023 deaths of her children. The defense argues she suffered from postpartum psychosis, while testimony focused on her concerns about medication addiction.
Why it matters
The case highlights complex legal and medical debates surrounding postpartum mental health and criminal responsibility.
Jurors heard details Tuesday about weeks of mental health treatment and medication prescription during the murder trial of Lindsay Clancy, the Massachusetts mother accused of strangling her three children in the family's Duxbury home in 2023. Jurors heard from a psychiatric nurse practitioner who treated Lindsay Clancy in the months before the children's deaths. Rebecca Jollotta works at South Shore Hospital and said she started meeting with Lindsay Clancy in November 2022. Jollotta said the defendant feared she might be addicted to Ativan — an anti-anxiety medication — and was relying on it to sleep. During the course of a few days, Jollotta said Lindsay Clancy sent multiple messages through a chat portal about her concerns and symptoms, saying she was having intrusive thoughts. Jollotta testified that she responded that this was normal. "I said, 'It sounds more like depression than side effects.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in